ALPN(Delisted)
Alpine Immune·NASDAQ
--
--(--)
ALPN fundamentals
Alpine Immune (ALPN) released its earnings on Mar 28, 2018: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 28, 2018
EPS
Revenue
Revenue & Expenses
ALPN has released its 2024 Q1 earnings report, with revenue of 7.03M, reflecting a YoY change of -25.09%, and net profit of -17.92M, showing a YoY change of -35.07%. The Sankey diagram below clearly presents ALPN's revenue sources and cost distribution.
Key Indicators
Alpine Immune (ALPN) key financial stats and ratios, covering profitability, financial health, and leverage.
Alpine Immune (ALPN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Alpine Immune (ALPN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Alpine Immune (ALPN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Alpine Immune (ALPN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Alpine Immune (ALPN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
